General MedicationsORALGeneric
NITROFURANTOIN
NITROFURANTOIN
Standard Dose
100MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview NITROFURANTOIN is listed in Drugs@FDA under application 084326 (ANDA).
Marketing status: Discontinued Active ingredient NITROFURANTOIN Form and strength CAPSULE;ORAL - 100MG Sponsor WATSON LABS Submission history Latest submission status date: 1986-02-06 00:00:00.
Structured Monograph
Clinical summary
Approval overview NITROFURANTOIN is listed in Drugs@FDA under application 084326 (ANDA). Marketing status: Discontinued Active ingredient NITROFURANTOIN Form and strength CAPSULE;ORAL - 100MG Sponsor WATSON LABS Submission history Latest submission status date: 1986-02-06 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.